In part 1 of this Exclusive Interview, Dr. Aaron Kowalski talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about his role at the JDRF and the studies getting their support.
Aaron Kowalski, PhD is the Chief Mission Officer and Vice President of Research at the JDRF. He is an internationally recognized expert in the area of diabetes technologies and has been a leader of JDRF’s Artificial Pancreas Research Project, a multimillion dollar initiative that began in 2005 to accelerate the progress toward automated insulin delivery systems.
Transcript of this video segment:
Steve Freed: This is Steve Freed with Diabetes in Control and we’re here at the American Diabetes Association 77th scientific session 2017. We’re here to present you some really exciting interviews with some of the top endos from all across the world. And we have a special guest with us. Aaron Kowalski, PhD who has a very unique job. Maybe you can start off with, tell us a little bit about yourself and just a little bit about your background.
Aaron Kowalski: Sure, well thanks for having me. This is another great ADA scientific sessions and I’m JDRF’s Chief Mission Officer. I joined JDRF as a scientist working in our diabetes complications portfolio and now have the pleasure and honor of working with our research team on our funding. I also oversee our policy efforts because ultimately JDRF is about curing type 1 diabetes and keeping people healthy and happy until we get to a cure. And to do that we need research, but research needs to be translated through regulatory approvals. It needs to be accessible and affordable. Doctors need to prescribe advances before people benefit and my title of Chief Mission Officer, the mission is people doing better until we drive and cure this disease and that’s what I focus on at JDRF.
Steve Freed: And that’s pretty important. How many studies are you supporting from JDRF?
Aaron Kowalski: I’m really proud of the amount of type 1 diabetes research JDRF funds. We will fund over 80 million dollars in research this year and have many abstracts and oral presentations at the scientific sessions, which is really exciting to see the research get reported out.
Steve Freed: What’s the most exciting presentation, if you have to pick one?
Aaron Kowalski: Well, I can’t just pick one. I mean that’s unfair because we fund across a variety of different programs. In the nearest term, we are going to see devices really helping people with diabetes and I think of the artificial pancreas work that JDRF supported. I have been fortunate to work on that program for a number of years now. This meeting was super exciting because we are seeing the launch of the first hybrid close loop system and that’s really amazing.